SCHEMBL3767340

SCHEMBL3767340

O=C1CCCc2c1sc(N1CCOCC1)c2C(=O)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
GAA P10253 3/20 0.46
HPGD P15428 1/20 0.46
CHRNA7 P36544 2/20 0.45
PIK3R1 P27986 1/20 0.42
PIK3CA P42336 1/20 0.42
CYP2C19 P33261 2/20 0.42
CYP2C9 P11712 1/20 0.42
MAPT P10636 5/20 0.42
HIF1A Q16665 2/20 0.42
KDM4E B2RXH2 1/20 0.42
PTPN11 Q06124 1/20 0.42
LMNA P02545 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
MCL1 Q07820 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760404 0.78 MAPT (0.51) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL3751674 0.77 HSD17B10 (0.43) ALDH1A1GAAPIK3R1PIK3CAKDM4E
SCHEMBL16161774 0.76 GRM5 (0.46) PIK3R1PIK3CA
SCHEMBL3757639 0.74 PIK3CD (0.41) ALDH1A1GAAHPGDPIK3CACYP2C19
SCHEMBL3764951 0.73 PIK3CD (0.40) ALDH1A1GAAHPGDPIK3CACYP2C19
SCHEMBL3759549 0.72 PRKDC (0.44) PIK3CA
SCHEMBL360530 0.72 ALDH1A1 (0.67) ALDH1A1GAAHPGDPIK3CAMAPT
SCHEMBL3764986 0.71 PIK3CD (0.49) ALDH1A1GAAHPGDPIK3CAKDM4E
SCHEMBL3765735 0.71 PIK3CD (0.49) ALDH1A1GAAPIK3CAKDM4ELMNA
SCHEMBL3766049 0.70 PIK3CA (0.46) ALDH1A1HPGDPIK3R1PIK3CAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA ALDH1A1 3061/4885GAA 1593/4885HPGD 3366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.